The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Abstract
Objective: Degeneration of chronically demyelinated axons is a major cause of irreversible neurological disability in multiple sclerosis (MS) patients. Development of neuroprotective therapies will require elucidation of the molecular mechanisms by which neurons and axons degenerate. Methods: We report ultrastructural changes that support Ca2+‐mediated destruction of chronically demyelinated axons in MS patients. We compared expression levels of 33,000 characterized genes in postmortem motor cortex from six control and six MS brains matched for age, sex, and postmortem interval. As reduced energy production is a major contributor to Ca2+‐mediated axonal degeneration, we focused on changes in oxidative phosphorylation and inhibitory neurotransmission. Results: Compared with controls, 488 transcripts were decreased and 67 were increased (p < 0.05, 1.5‐fold) in the MS cortex. Twenty‐six nuclear‐encoded mitochondrial genes and the functional activities of mitochondrial respiratory chain complexes I and III were decreased in the MS motor cortex. Reduced mitochondrial gene expression was specific for neurons. In addition, pre‐synaptic and postsynaptic components of GABAergic neurotransmission and the density of inhibitory interneuron processes also were decreased in the MS cortex. Interpretation: Our data supports a mechanism whereby reduced ATP production in demyelinated segments of upper motor neuron axons impacts ion homeostasis, induces Ca2+‐mediated axonal degeneration, and contributes to progressive neurological disability in MS patients. Ann Neurol 2006
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data
Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., et al. (2001) · Nature Genetics · doi:10.1038/ng1201-365 · Cited by 4,109
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Self-citationNoseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Identifying biological themes within lists of genes with EASE
Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-10-r70 · Cited by 1,950
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 1×
“It is possible that this microglial response is initially neuroprotective as reducing inhibitory innervation of motor neurons increases firing of synaptic NMDA (N-methyl-D-aspartate) receptors and inhibits cell death pathways by triggering cAMP-response element binding protein (CREB) activity and brain-derived neurotr…”
BackgroundLock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Self-citationMicroglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,119
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938
Self-citation
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Self-citationRemyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
“This in turn will activate intra-axonal proteases, resulting in neurofilament fragmentation and perturbation of axon transport and integrit”
BackgroundThe Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Pathological mechanisms in progressive multiple sclerosis
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,137
Self-citationProgressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Lassmann, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028936 · Cited by 937
“This process is associated with mitochondrial damage reflected by the presence of respiratory-deficient cells and the accumulation of mitochondrial gene deletions (Dutta et al. 2006; Mahad et al. 2008; Campbell et al. 2011).”
BackgroundThe Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
Oxidative damage in multiple sclerosis lesions
Haider, L., Fischer, M. T., Frischer, J. M., Bauer, J., Hoftberger, R., Botond, G., Esterbauer, H., Binder, C. J., Witztum, J. L., & Lassmann, H. (2011) · Brain · doi:10.1093/brain/awr128 · Cited by 753
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713
“Our findings provide a mechanistic framework for recent histopathological studies that showed damage to neuronal mitochondria in acute and chronic stages of multiple sclerosi”
ResultRegenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621
Self-citationIron and neurodegeneration in the multiple sclerosis brain
Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Brück, W., & Lassmann, H. (2013) · Annals of Neurology · doi:10.1002/ana.23974 · Cited by 519
Fischer, M. T., Sharma, R., Lim, J. L., Haider, L., Frischer, J. M., Drexhage, J., Mahad, D., Bradl, M., van Horssen, J., & Lassmann, H. (2012) · Brain · doi:10.1093/brain/aws012 · Cited by 507
Grey matter pathology in multiple sclerosis
Geurts, J. J., & Barkhof, F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70191-1 · Cited by 507
The experimental autoimmune encephalomyelitis (EAE) model of MS
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00008-x · Cited by 464
Scannevin, R. H., Chollate, S., Jung, M.-Y., Shackett, M., Patel, H., Bista, P., Zeng, W., Ryan, S., Yamamoto, M., Lukashev, M., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190132 · Cited by 461
The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative Diseases
Cannon, J. R., & Greenamyre, J. T. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr239 · Cited by 459
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Dutta, R., & Trapp, B. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.005 · Cited by 457
Self-citationMitochondrial changes within axons in multiple sclerosis
Mahad, D. J., Ziabreva, I., Campbell, G., Lax, N., White, K., Hanson, P. S., Lassmann, H., & Turnbull, D. M. (2009) · Brain · doi:10.1093/brain/awp046 · Cited by 454
“(Dutta et al., 2006; Mahad et al., 2008), syntaphilin—a mitochondrial docking protein expressed specifically within”
InfluentialMitochondrial DNA damage and reactive oxygen species in neurodegenerative disease
Nissanka, N., & Moraes, C. T. (2018) · FEBS Letters · doi:10.1002/1873-3468.12956 · Cited by 444
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Dutta, R., & Trapp, B. D. (2007) · Neurology · doi:10.1212/01.wnl.0000275229.13012.32 · Cited by 412
Self-citationFriese, M. A., Craner, M. J., Etzensperger, R., Vergo, S., Wemmie, J. A., Welsh, M. J., Vincent, A., & Fugger, L. (2007) · Nature Medicine · doi:10.1038/nm1668 · Cited by 408
Mitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406
“, 2003) and decreased expression of mRNA for mitochondrial proteins (Dutta et al., 2006).”
BackgroundHow do immune cells overcome the blood-brain barrier in multiple sclerosis?
Larochelle, C., Alvarez, J. I., & Prat, A. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.066 · Cited by 405
“formation of ROS and lead to oligodendrocyte damage and axonal degeneration [135].”
BackgroundAxonal conduction and injury in multiple sclerosis: the role of sodium channels
Waxman, S. G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2023 · Cited by 397
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
Choi, S. R., Howell, O. W., Carassiti, D., Magliozzi, R., Gveric, D., Muraro, P. A., Nicholas, R., Roncaroli, F., & Reynolds, R. (2012) · Brain · doi:10.1093/brain/aws189 · Cited by 386
Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
Campbell, G. R., Ziabreva, I., Reeve, A. K., Krishnan, K. J., Reynolds, R., Howell, O., Lassmann, H., Turnbull, D. M., & Mahad, D. J. (2011) · Annals of Neurology · doi:10.1002/ana.22109 · Cited by 386
Zipp, F., & Aktas, O. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.006 · Cited by 348
The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
Oksenberg, J. R., Baranzini, S. E., Sawcer, S., & Hauser, S. L. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2395 · Cited by 347
“Low- and high-capacity microarray studies of the MS brain lesion have been publishe”
BackgroundLinking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia
Takahashi, N., Sakurai, T., Davis, K. L., & Buxbaum, J. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.004 · Cited by 337
Radical changes in multiple sclerosis pathogenesis
van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 322
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients
Dutta, R., Chang, A., Doud, M. K., Kidd, G. J., Ribaudo, M. V., Young, E. A., Fox, R. J., Staugaitis, S. M., & Trapp, B. D. (2011) · Annals of Neurology · doi:10.1002/ana.22337 · Cited by 315
Self-citationDisease-specific molecular events in cortical multiple sclerosis lesions
Fischer, M. T., Wimmer, I., Höftberger, R., Gerlach, S., Haider, L., Zrzavy, T., Hametner, S., Mahad, D., Binder, C. J., Krumbholz, M., et al. (2013) · Brain · doi:10.1093/brain/awt110 · Cited by 311
“They revealed changes related to mitochondrial function in the non-demyelinated motor cortex (Dutta et al., 2006), to axonal transport and synaptic function (Dutta et al.”
BackgroundPathology of multiple sclerosis and related inflammatory demyelinating diseases
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00002-9 · Cited by 303
The molecular basis of neurodegeneration in multiple sclerosis
Lassmann, H., & van Horssen, J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.004 · Cited by 294
Mitochondrial Dysfunction and Multiple Sclerosis
Barcelos, I. P. D., Troxell, R. M., & Graves, J. S. (2019) · Biology · doi:10.3390/biology8020037 · Cited by 291
Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders?
van Horssen, J., van Schaik, P., & Witte, M. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2017.06.050 · Cited by 283
Inflammation, demyelination, and degeneration — Recent insights from MS pathology
Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Witte, M. E., Mahad, D. J., Lassmann, H., & van Horssen, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.007 · Cited by 278
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245
“Complex I and Complex III activity is also reduced in normal tissue within the motor cortex [81].”
BackgroundReview: Mitochondria and disease progression in multiple sclerosis
Mahad, D., Lassmann, H., & Turnbull, D. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00987.x · Cited by 193
Mechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191
“2c; Lu et al., 2000, Dutta et al., 2006, Mahad et al., 2008).”
Genetic factors influencing alcohol dependence
Mayfield, R. D., Harris, R. A., & Schuckit, M. A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.88 · Cited by 186
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability
Politis, M., Giannetti, P., Su, P., Turkheimer, F., Keihaninejad, S., Wu, K., Waldman, A., Malik, O., Matthews, P. M., Reynolds, R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182635645 · Cited by 176
Mechanisms underlying progression in multiple sclerosis
Absinta, M., Lassmann, H., & Trapp, B. D. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000818 · Cited by 175
“With time, however, the function of axonal mitochondria is compromised by reductions in mitochondrial gene expression in neurons [44], mtDNA mutations [63] and oxidative stress (nitric oxide and free radicals released from activated microglia and iron accumulation) [62].”
BackgroundSelf-citationThe translational biology of remyelination: past, present, and future
Franklin, R. J. M., & Gallo, V. (2014) · Glia · doi:10.1002/glia.22622 · Cited by 162
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis
Vogt, J., Paul, F., Aktas, O., Müller‐Wielsch, K., Dörr, J., Dörr, S., Bharathi, B. S., Glumm, R., Schmitz, C., Steinbusch, H., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21719 · Cited by 157
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice
Han, M. H., Lundgren, D. H., Jaiswal, S., Chao, M., Graham, K. L., Garris, C. S., Axtell, R. C., Ho, P. P., Lock, C. B., Woodard, J. I., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20101974 · Cited by 157
Dulamea, A. O. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-47861-6_7 · Cited by 128
Mháille, A. N., McQuaid, S., Windebank, A., Cunnea, P., McMahon, J., Samali, A., & FitzGerald, U. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318165b239 · Cited by 128
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities
Macrez, R., Stys, P. K., Vivien, D., Lipton, S. A., & Docagne, F. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30165-x · Cited by 127
Human myelin proteome and comparative analysis with mouse myelin
Ishii, A., Dutta, R., Wark, G. M., Hwang, S.-I., Han, D. K., Trapp, B. D., Pfeiffer, S. E., & Bansal, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905936106 · Cited by 119
Self-citationMechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease
Lassmann, H. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0607-8 · Cited by 112
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis
Rossi, S., Muzio, L., De Chiara, V., Grasselli, G., Musella, A., Musumeci, G., Mandolesi, G., De Ceglia, R., Maida, S., Biffi, E., et al. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.004 · Cited by 112
“These data point to GABAergic interneurons as the primary cell-type population compromised by EAE, and are in good agreement with previous findings showing selective loss of PV interneurons, and reduced extension of PV-positive neurites in the normal appearing gray matter and in the motor cortex of MS patients (Dutta…”
Progressive multiple sclerosis
Bradl, M., & Lassmann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0182-3 · Cited by 108
Geisler, J. G. (2019) · Cells · doi:10.3390/cells8030280 · Cited by 104
“Postmortem comparison of MS brain to non-MS, suggests changes in gene expression related to mitochondrial ATP production specific to neurons and Ca2+ mediated demyelination [113].”
BackgroundWarne, J., Pryce, G., Hill, J. M., Shi, X., Lennerås, F., Puentes, F., Kip, M., Hilditch, L., Walker, P., Simone, M. I., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700385 · Cited by 99
“CypD is highly expressed in a subset of astrocytes, microglia, and neurons (19), where it may contribute to excitotoxicity and cell death in MS lesions (12, 16, 17).”
Nijland, P. G., Witte, M. E., van het Hof, B., van der Pol, S., Bauer, J., Lassmann, H., van der Valk, P., de Vries, H. E., & van Horssen, J. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0170-2 · Cited by 96
Vyshkina, T., Sylvester, A., Sadiq, S., Bonilla, E., Canter, J. A., Perl, A., & Kalman, B. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.011 · Cited by 90
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
Albanese, M., Zagaglia, S., Landi, D., Boffa, L., Nicoletti, C. G., Marciani, M. G., Mandolesi, G., Marfia, G. A., Buttari, F., Mori, F., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0502-1 · Cited by 88
The histopathology of grey matter demyelination in multiple sclerosis
Bø, L. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01216.x · Cited by 58
Pathogenesis of Multiple Sclerosis: What Can We Learn from the Cuprizone Model
Acs, P., & Kalman, B. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-60761-720-4_20 · Cited by 42
Alternative platelet activation pathways and their role in neurodegenerative diseases
Ferrer-Raventós, P., & Beyer, K. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105512 · Cited by 39
Relationship of iron metabolism and short-term cuprizone treatment of c57bl/6 mice
Pandur, E., Pap, R., Varga, E., Jánosa, G., Komoly, S., Fórizs, J., & Sipos, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092257 · Cited by 21
“In CZ-affected brain regions, particularly in the corpus callosum, axonal injuries, microglia accumulation, and mitochondrial dysfunction can be observed [15,16].”
BackgroundBuonvicino, D., Ranieri, G., Pratesi, S., Guasti, D., & Chiarugi, A. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113065 · Cited by 18
Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model
Tahmasebi, F., Barati, S., & Kashani, I. R. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102179 · Cited by 17
Buonvicino, D., Ranieri, G., Pratesi, S., Gerace, E., Muzzi, M., Guasti, D., Tofani, L., & Chiarugi, A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15058 · Cited by 15
Investigation of cytocrom c oxidase gene subunits expression on the Multiple sclerosis
Zaefizadeh, M., Safavizadeh, N., & Rahmani, S. (2013) · Indian Journal of Human Genetics · doi:10.4103/0971-6866.112879 · Cited by 12
Scalabrino, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040815 · Cited by 10
Metadata
- Authors
- Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W. B., Lewis, D. A., Fox, R. J., Rudick, R., Mirnics, K., & Trapp, B. D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2006-02-17
- Volume
- 59
- Issue
- 3
- Pages
- 478-489
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2139843103
- Cited by
- 841
- References
- 50
- FWCI
- 29.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.